WOOF

WOOF
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.464B ▼ | $539.819M ▼ | $9.33M ▼ | 0.637% ▼ | $0.03 ▼ | $29.196M ▼ |
| Q2-2025 | $1.489B ▼ | $542.297M ▼ | $13.972M ▲ | 0.939% ▲ | $0.05 ▲ | $93.215M ▲ |
| Q1-2025 | $1.493B ▼ | $553.609M ▼ | $-11.661M ▲ | -0.781% ▲ | $-0.042 ▲ | $67.083M ▼ |
| Q4-2024 | $1.552B ▲ | $571.872M ▲ | $-13.837M ▲ | -0.891% ▲ | $-0.05 ▲ | $68.09M ▲ |
| Q3-2024 | $1.511B | $571.78M | $-16.673M | -1.103% | $-0.06 | $63.897M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $237.413M ▲ | $5.205B ▲ | $4.048B ▲ | $1.158B ▲ |
| Q2-2025 | $188.748M ▲ | $5.153B ▲ | $4.014B ▲ | $1.139B ▲ |
| Q1-2025 | $133.343M ▼ | $5.121B ▼ | $4.014B ▼ | $1.107B ▼ |
| Q4-2024 | $165.756M ▲ | $5.194B ▼ | $4.081B ▼ | $1.114B ▼ |
| Q3-2024 | $116.675M | $5.211B | $4.089B | $1.123B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $13.972M ▲ | $85.892M ▲ | $-30.958M ▼ | $-3.946M ▼ | $50.988M ▲ | $53.788M ▲ |
| Q1-2025 | $-11.661M ▲ | $-15.454M ▼ | $-27.133M ▲ | $-334K ▲ | $-42.921M ▼ | $-43.866M ▼ |
| Q4-2024 | $-13.837M ▲ | $95.993M ▲ | $-34.397M ▼ | $-952K ▲ | $60.644M ▲ | $59.044M ▲ |
| Q3-2024 | $-16.673M ▲ | $20.724M ▼ | $-31.441M ▼ | $-1.908M ▼ | $-12.625M ▼ | $-10.288M ▼ |
| Q2-2024 | $-24.823M | $69.37M | $-26.322M | $-266K | $42.782M | $41.982M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Consumables | $740.00M ▲ | $750.00M ▲ | $750.00M ▲ | $730.00M ▼ |
Services And Other | $260.00M ▲ | $250.00M ▼ | $250.00M ▲ | $260.00M ▲ |
Supplies And Companion Animals | $520.00M ▲ | $510.00M ▼ | $490.00M ▼ | $500.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Petco is in the middle of a strategic transition from being mainly a pet retailer to being a broader health-and-wellness platform for pets, anchored by services and digital engagement. The strategy has clear logic and could deepen loyalty, but it has not yet translated into strong or steady profits, and financial leverage adds pressure to deliver. Cash generation is adequate but not abundant, which constrains how aggressively the company can invest while absorbing short-term hits to earnings. Going forward, the key things to watch are whether service revenues and membership programs scale as intended, whether cost efficiencies show up in margins, and whether the company can strengthen its balance sheet while executing this pivot.
NEWS
November 25, 2025 · 4:05 PM UTC
Petco Reports Third Quarter 2025 Financial Results
Read more
November 11, 2025 · 4:05 PM UTC
Petco to Host Third Quarter 2025 Earnings Conference Call on Nov. 25, 2025
Read more
September 24, 2025 · 2:10 PM UTC
Kuehn Law Encourages Investors of Petco Health and Wellness Company, Inc. to Contact Law Firm
Read more
September 2, 2025 · 2:17 PM UTC
Johnson Fistel Begins Investigation on Behalf of Petco Health and Wellness Company, Inc. Long-Term Shareholders
Read more
September 2, 2025 · 8:45 AM UTC
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 29, 2025 in Petco Health and Wellness Company, Inc. Lawsuit - WOOF
Read more
About Petco Health and Wellness Company, Inc.
https://corporate.petco.comPetco Health and Wellness Company, Inc., a health and wellness company, focuses on enhancing the lives of pets, pet parents, and its Petco partners. The company provides veterinary care, grooming, training, tele-health, and Vital Care and pet health insurance services, as well as veterinary services through Vetco mobile clinics.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.464B ▼ | $539.819M ▼ | $9.33M ▼ | 0.637% ▼ | $0.03 ▼ | $29.196M ▼ |
| Q2-2025 | $1.489B ▼ | $542.297M ▼ | $13.972M ▲ | 0.939% ▲ | $0.05 ▲ | $93.215M ▲ |
| Q1-2025 | $1.493B ▼ | $553.609M ▼ | $-11.661M ▲ | -0.781% ▲ | $-0.042 ▲ | $67.083M ▼ |
| Q4-2024 | $1.552B ▲ | $571.872M ▲ | $-13.837M ▲ | -0.891% ▲ | $-0.05 ▲ | $68.09M ▲ |
| Q3-2024 | $1.511B | $571.78M | $-16.673M | -1.103% | $-0.06 | $63.897M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $237.413M ▲ | $5.205B ▲ | $4.048B ▲ | $1.158B ▲ |
| Q2-2025 | $188.748M ▲ | $5.153B ▲ | $4.014B ▲ | $1.139B ▲ |
| Q1-2025 | $133.343M ▼ | $5.121B ▼ | $4.014B ▼ | $1.107B ▼ |
| Q4-2024 | $165.756M ▲ | $5.194B ▼ | $4.081B ▼ | $1.114B ▼ |
| Q3-2024 | $116.675M | $5.211B | $4.089B | $1.123B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $13.972M ▲ | $85.892M ▲ | $-30.958M ▼ | $-3.946M ▼ | $50.988M ▲ | $53.788M ▲ |
| Q1-2025 | $-11.661M ▲ | $-15.454M ▼ | $-27.133M ▲ | $-334K ▲ | $-42.921M ▼ | $-43.866M ▼ |
| Q4-2024 | $-13.837M ▲ | $95.993M ▲ | $-34.397M ▼ | $-952K ▲ | $60.644M ▲ | $59.044M ▲ |
| Q3-2024 | $-16.673M ▲ | $20.724M ▼ | $-31.441M ▼ | $-1.908M ▼ | $-12.625M ▼ | $-10.288M ▼ |
| Q2-2024 | $-24.823M | $69.37M | $-26.322M | $-266K | $42.782M | $41.982M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Consumables | $740.00M ▲ | $750.00M ▲ | $750.00M ▲ | $730.00M ▼ |
Services And Other | $260.00M ▲ | $250.00M ▼ | $250.00M ▲ | $260.00M ▲ |
Supplies And Companion Animals | $520.00M ▲ | $510.00M ▼ | $490.00M ▼ | $500.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Petco is in the middle of a strategic transition from being mainly a pet retailer to being a broader health-and-wellness platform for pets, anchored by services and digital engagement. The strategy has clear logic and could deepen loyalty, but it has not yet translated into strong or steady profits, and financial leverage adds pressure to deliver. Cash generation is adequate but not abundant, which constrains how aggressively the company can invest while absorbing short-term hits to earnings. Going forward, the key things to watch are whether service revenues and membership programs scale as intended, whether cost efficiencies show up in margins, and whether the company can strengthen its balance sheet while executing this pivot.
NEWS
November 25, 2025 · 4:05 PM UTC
Petco Reports Third Quarter 2025 Financial Results
Read more
November 11, 2025 · 4:05 PM UTC
Petco to Host Third Quarter 2025 Earnings Conference Call on Nov. 25, 2025
Read more
September 24, 2025 · 2:10 PM UTC
Kuehn Law Encourages Investors of Petco Health and Wellness Company, Inc. to Contact Law Firm
Read more
September 2, 2025 · 2:17 PM UTC
Johnson Fistel Begins Investigation on Behalf of Petco Health and Wellness Company, Inc. Long-Term Shareholders
Read more
September 2, 2025 · 8:45 AM UTC
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 29, 2025 in Petco Health and Wellness Company, Inc. Lawsuit - WOOF
Read more

CEO
Joel D. Anderson
Compensation Summary
(Year 2024)

CEO
Joel D. Anderson
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades

Goldman Sachs
Buy

RBC Capital
Outperform

Wedbush
Outperform

Wells Fargo
Equal Weight

Morgan Stanley
Equal Weight

Guggenheim
Neutral

UBS
Neutral

Baird
Neutral

Citigroup
Neutral

Jefferies
Hold
Grade Summary
Price Target
Institutional Ownership

CVC MANAGEMENT HOLDINGS II LTD.
145.924M Shares
$466.957M

CVC CAPITAL PARTNERS VI LTD
145.924M Shares
$466.957M

CANADA PENSION PLAN INVESTMENT BOARD
59.765M Shares
$191.249M

DIMENSIONAL FUND ADVISORS LP
9.312M Shares
$29.798M

BLACKROCK INC.
8.847M Shares
$28.309M

VANGUARD GROUP INC
8.416M Shares
$26.933M

BLACKROCK, INC.
8.189M Shares
$26.206M

LONG FOCUS CAPITAL MANAGEMENT, LLC
6.4M Shares
$20.48M

HOLOCENE ADVISORS, LP
6.092M Shares
$19.493M

FMR LLC
3.748M Shares
$11.993M

MORGAN STANLEY
3.405M Shares
$10.897M

TWO SIGMA ADVISERS, LP
2.656M Shares
$8.501M

TWO SIGMA INVESTMENTS, LP
2.639M Shares
$8.444M

GOLDMAN SACHS GROUP INC
2.608M Shares
$8.346M

CRESSET ASSET MANAGEMENT, LLC
2.518M Shares
$8.058M

BRIDGEWAY CAPITAL MANAGEMENT, LLC
2.321M Shares
$7.427M

NUVEEN, LLC
2.198M Shares
$7.033M

GEODE CAPITAL MANAGEMENT, LLC
2.14M Shares
$6.848M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
2.109M Shares
$6.749M

NUVEEN ASSET MANAGEMENT, LLC
2.102M Shares
$6.727M
Summary
Only Showing The Top 20

